A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.

[1]  Y. Okumura,et al.  Association of patient satisfaction with direct oral anticoagulants and the clinical outcomes: Findings from the SAKURA AF registry. , 2020, Journal of cardiology.

[2]  Y. Okumura,et al.  Different determinants of vascular and nonvascular deaths in patients with atrial fibrillation: A SAKURA AF Registry substudy. , 2019, Journal of cardiology.

[3]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2019, Journal of the American College of Cardiology.

[4]  A. Camm,et al.  The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.

[5]  Ching-Wei Tsai,et al.  Longitudinal change in estimated GFR among CKD patients: A 10-year follow-up study of an integrated kidney disease care program in Taiwan , 2017, PloS one.

[6]  A. Rule,et al.  The Substantial Loss of Nephrons in Healthy Human Kidneys with Aging. , 2017, Journal of the American Society of Nephrology : JASN.

[7]  Y. Ohashi,et al.  Cardiovascular events and death in Japanese patients with chronic kidney disease. , 2017, Kidney international.

[8]  A. Gómez-Outes,et al.  Causes of Death in Anticoagulated Patients With Atrial Fibrillation. , 2016, Journal of the American College of Cardiology.

[9]  S. Yusuf,et al.  Changes in Renal Function in Patients With Atrial Fibrillation: An Analysis From the RE-LY Trial. , 2015, Journal of the American College of Cardiology.

[10]  K. Aonuma,et al.  Anemia and reduced kidney function as risk factors for new onset of atrial fibrillation (from the Ibaraki prefectural health study). , 2015, The American journal of cardiology.

[11]  Harold I Feldman,et al.  KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[12]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[13]  G. Lip,et al.  Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). , 2013, The American journal of cardiology.

[14]  G. Marcus,et al.  Incident Atrial Fibrillation and Risk of End-Stage Renal Disease in Adults With Chronic Kidney Disease , 2013, Circulation.

[15]  G. Lip,et al.  Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation: A Systematic Review and Meta-Analysis of the Literature , 2012, Circulation.

[16]  L. Køber,et al.  Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.

[17]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[18]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[19]  K. Skorecki,et al.  Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. , 2011, JAMA.

[20]  Satoko Nakamura,et al.  Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients , 2010, Journal of hypertension.

[21]  A. Go,et al.  Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). , 2010, American heart journal.

[22]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[23]  D. Singer,et al.  Impact of Proteinuria and Glomerular Filtration Rate on Risk of Thromboembolism in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 2009, Circulation.

[24]  D. Roden,et al.  Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. , 2009, American heart journal.

[25]  K. Asayama,et al.  Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population--the Ohasama study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  T. Katsura,et al.  A prospective study on body weight curve from geriatric age to old age : Age and gender specific analysis using age cohort of 4 hundred thousands , 2005 .

[27]  K. Iseki,et al.  Proteinuria and the risk of developing end-stage renal disease. , 2003, Kidney international.